US Drug Recall Register

FDA Drug Recalls

2,661 recalls, newest first

Class II · Moderate risk Ongoing

Dianeal Low Calcium

Reason Lack of Assurance of Sterility: Potential presence of leaks originating from the Connector Assembly component.

Baxter Healthcare Corporation D-0587-2024
Class II · Moderate risk Ongoing

Zilretta

Reason Failed Dissolution Specifications - did not meet the acceptance criteria for IVR Level 3 testing at 9 months 2-8¿C followed by 6 weeks at 25¿C

Pacira Pharmaceuticals INC NDC 65250-003-01 D-0567-2024
Class II · Moderate risk Ongoing

Oatmeal Daily Moisturizing Body Lotion

Reason Microbial Contamination of Non-Sterile Products: confirmed presence of mold contamination

Brands International Corporation D-0598-2024
Class III · Low risk Ongoing

Eszopiclone Tablets

Reason Failed Impurities/Degradation Specifications: Related Substances

Dr. Reddy's Laboratories, Inc. NDC 55111-629-30 D-0581-2024
Class I · High risk Ongoing

Docetaxel Injection

Reason Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Sagent Pharmaceuticals NDC 25021-254-08 D-0554-2024
Class I · High risk Ongoing

Docetaxel Injection

Reason Presence of Particulate Matter: Presence of particulate matter from the stopper in the drug product.

Sagent Pharmaceuticals NDC 25021-254-08 D-0553-2024
Class III · Low risk Ongoing

Asmanex Twisthaler

Reason Defective Container

Organon Llc NDC 78206-0114-04 D-0552-2024
Class III · Low risk Ongoing

Asmanex Twisthaler

Reason Defective Container

Organon Llc NDC 78206-114-03 D-0551-2024
Class III · Low risk Ongoing

Asmanex Twisthaler

Reason Defective Container

Organon Llc NDC 78206-114-02 D-0550-2024
Class II · Moderate risk Ongoing

suntegrity

Reason CGMP Deviations

Synchronicity Spa INC, Dba Sunte D-0589-2024
Class I · High risk Ongoing

suntegrity

Reason Microbial Contamination of Non-Sterile Products: Presence of Aspergillus Sydowii (Mold)

Synchronicity Spa INC, Dba Sunte D-0588-2024
Class II · Moderate risk Ongoing

Dexamethasone Sodium Phosphate injection USP

Reason Failed Impurities/Degradation Specifications: impurity sulfonic acid adduct of dexamethasone phosphate results were above spec.

Eugia US LLC NDC 55150-239-30 D-0555-2024
Class III · Low risk Ongoing

Eptifibatide injection 20mg/10mL

Reason Failed Impurities/Degradation Specifications: failed related substance identified as Eptifibatide dimer.

Eugia US LLC NDC 55150-219-10 D-0556-2024
Class II · Moderate risk Ongoing

Labetalol Hydrochloride Injection

Reason Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Pfizer Inc. D-0565-2024
Class II · Moderate risk Ongoing

Buprenorphine Hydrochloride Injection

Reason Lack of Assurance of Sterility-The potential for incomplete crimp seals.

Pfizer Inc. D-0564-2024
Class III · Low risk Ongoing

Estradiol Transdermal System

Reason Failed Impurities/Degradation Specifications.

Zydus Pharmaceuticals (USA) Inc NDC 70710-1191-8 D-0543-2024